Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall. He speaks to "Bloomberg Open ...

BofA keeps a Buy rating on Catalyst Pharmaceuticals (CPRX) with a $30 price target following the announcement of a Firdapse patent settlement ...

Now, the Florida-based drugmaker has parried another Firdapse challenger in Teva Pharmaceuticals, which had hoped to market a generic version of the Lambert-Eaton myasthenic syndrome (LEMS ...

Lapatinib tablets are used with capecitabine to treat people with breast cancer that is advanced or that has spread to other parts of the body (metastatic), and that is HER2-positive (tumors that ...

Looking at Seeking Alpha's Quant Rating, TEVA has a Buy rating with a score of 4.4 out of 5. The company received A in the prospect of profitability, A in momentum, while it got a C+ growth factor.

Teva cannot market its generic version of Firdapse in the U.S. before February 25, 2035, unless specific conditions arise. Ongoing Firdapse patent litigation continues against Hetero and Lupin ...

5 Highest Paying Countries for Pharmacists A close-up shot of various types of medicines on a table, illustrating the specialty and generic products offered by the pharmaceutical company.

Catalyst Pharmaceuticals, Inc. has reached a Settlement Agreement with Teva Pharmaceuticals regarding patent litigation over the generic version of FIRDAPSE® (amifampridine) 10 mg tablets.

this almost made me turn around and decide not to buy the product after all, especially given the sensitivity of the product.” Lemonaid offers one of the lowest prices for generic Viagra online.

Teva Pharmaceutical is the leading generic drug manufacturer in the world ... and as a result they can demand higher buy-side discounts and rebates from generics manufacturers, ultimately eating ...

Duvakitug is a monoclonal antibody targeting a proinflammatory cytokine called TL1A, which, as I already noted in the article "Teva Pharmaceutical: Buy This Bargain Before It's Gone," demonstrated ...